Cellular Immune Response
We are a regulated and innovative service and product provider for all peptide related projects in immune and cellular therapy, vaccine development and immunomonitoring. Our proprietary technologies help to advance novel diagnostic and therapeutic approaches for cancer, infectious and autoimmune diseases as well as allergies.
JPT offers the widest range of products and services to address cellular immunity. They include peptide libraries enabling fast target discovery and neo-epitope qualification, peptide pools for reliable clinical immune monitoring, as well as clinical peptides for cell- and immunotherapy.